Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a t cell lymphoma: Comparison with the effects of rapamycin

Transforming growth factor β1 (TGF‐β1) is a multifunctional cytokine whose potent immunomodulatory activity is well documented. To explore the mechanisms of this activity we examined the effect of TGF‐β1 on the production of IFN‐γ measured at the mRNA and protein levels in the YAC‐1 cell lymphoma. I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular physiology 1994-07, Vol.160 (1), p.141-153
Hauptverfasser: Dumont, Francis J., Kastner, Carolyn A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 153
container_issue 1
container_start_page 141
container_title Journal of cellular physiology
container_volume 160
creator Dumont, Francis J.
Kastner, Carolyn A.
description Transforming growth factor β1 (TGF‐β1) is a multifunctional cytokine whose potent immunomodulatory activity is well documented. To explore the mechanisms of this activity we examined the effect of TGF‐β1 on the production of IFN‐γ measured at the mRNA and protein levels in the YAC‐1 cell lymphoma. In previous studies, this model proved useful to characterize the mode of action of the immunosuppressant rapamycin (RAP). Here, we found that when induced by IL‐1 or IL‐1 + PMA, the production of IFN‐γ is suppressed by both TGF‐β1 (ED50 = 1.9 pM) and RAP (ED50 = 0.2 nM). In contrast, when induced by the calcium ionophore ionomycin, in the absence or in the presence of PMA, this production is enhanced up to 10‐fold by TGF‐β (ED50 = 1.8 pM) and 1.5—3‐fold by RAP. Therefore, in YAC‐1 cells, TGF‐β1 exerts opposite effects on IFN‐γ production depending on the mode of activiation, and these effects parallel those of RAP. To further analyze the mode of action of TGF‐β1 in this system, we used okadaic acid (OA), an inhibitor of serine/threonine protein phosphatases. Treatment with OA rendered the expression of IFN‐γ mRNA induced by IL‐1 insensitive to TGF‐β1 or RAP, indicating that activation of a phosphatase may play a role in the suppressive effect of both agents. However, OA did not prevent the augmentation of ionomycin‐mediated induction of IFN‐β mRNA by either TGF‐β1 or RAP. Hence, the up‐regulation of IFN‐β production by TGF‐β1 and RAP may involve a different biochemical mechanism that that mediating their suppressive action. These observations also favor the hypothesis that the two agents act on the same regulatory pathways. This was further supported by the finding that TGF‐β1 and RAP modulate IFN‐γ production in an additive rather than synergistic fashion. However, their effects could be dissociated in mutants of YAC‐1 cells selected for resistance to the inhibition of IL‐1‐mediated IFN‐γ induction by RAP. Moreover, the IFN‐γ modulatory action of RAP in YAC‐1 cells was accompanied by an antiproliferative effect, whereas TGF‐β1 failed to alter the growth of these cells. Therefore, the immunomodulatory action of TGF‐β1 may result from the dis ruption of biochemical processes related to, although distinct from, those affected by RAP. © 1994 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcp.1041600117
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jcp_1041600117</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JCP1041600117</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2697-16562673642acc8ad20b24803a60fe09a8453602f1599e85e754bb3348ba11293</originalsourceid><addsrcrecordid>eNqFkM1u1DAUhS0EEkNhy9oLtin-T8wORbSlGgFCRSwtx2M3bhM7sj2azmtBn6PPhNuBIlasfOX7nXPvPQC8xugYI0TeXpmlFgwLhDBun4AVRrJtmODkKVhVADeSM_wcvMj5CiEkJaUrcHuRdMguptmHS3iZ4q6M0GlTYoJ3PzD0YfSDL7kWxabJbq99aHDjw2Zr7AYO2wJtGHUwtiIxxHlvKvCn_SByNsXQ3P2ES4r1u1SsNqCGBRo7TXDaz8sYZ_0O9nFedPK5Ajtf9yijhdY5a-r86GDSi37wfwmeOT1l--r3ewS-nXy46M-a9efTj_37dWOIqKdjwQURLRWMaGM6vSFoIKxDVAvkLJK6Y5wKRBzmUtqO25azYaCUdYPGmEh6BI4PvibFnJN1akl-1mmvMFL3mauaufqbeRW8OQgWnY2eXM3W-PyoYri7d6-YPGA7P9n9f0zVef_lnxHNQetzsTePWp2uVT215er7p1PVnfS8X1OpvtJf2Jal3A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a t cell lymphoma: Comparison with the effects of rapamycin</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Dumont, Francis J. ; Kastner, Carolyn A.</creator><creatorcontrib>Dumont, Francis J. ; Kastner, Carolyn A.</creatorcontrib><description>Transforming growth factor β1 (TGF‐β1) is a multifunctional cytokine whose potent immunomodulatory activity is well documented. To explore the mechanisms of this activity we examined the effect of TGF‐β1 on the production of IFN‐γ measured at the mRNA and protein levels in the YAC‐1 cell lymphoma. In previous studies, this model proved useful to characterize the mode of action of the immunosuppressant rapamycin (RAP). Here, we found that when induced by IL‐1 or IL‐1 + PMA, the production of IFN‐γ is suppressed by both TGF‐β1 (ED50 = 1.9 pM) and RAP (ED50 = 0.2 nM). In contrast, when induced by the calcium ionophore ionomycin, in the absence or in the presence of PMA, this production is enhanced up to 10‐fold by TGF‐β (ED50 = 1.8 pM) and 1.5—3‐fold by RAP. Therefore, in YAC‐1 cells, TGF‐β1 exerts opposite effects on IFN‐γ production depending on the mode of activiation, and these effects parallel those of RAP. To further analyze the mode of action of TGF‐β1 in this system, we used okadaic acid (OA), an inhibitor of serine/threonine protein phosphatases. Treatment with OA rendered the expression of IFN‐γ mRNA induced by IL‐1 insensitive to TGF‐β1 or RAP, indicating that activation of a phosphatase may play a role in the suppressive effect of both agents. However, OA did not prevent the augmentation of ionomycin‐mediated induction of IFN‐β mRNA by either TGF‐β1 or RAP. Hence, the up‐regulation of IFN‐β production by TGF‐β1 and RAP may involve a different biochemical mechanism that that mediating their suppressive action. These observations also favor the hypothesis that the two agents act on the same regulatory pathways. This was further supported by the finding that TGF‐β1 and RAP modulate IFN‐γ production in an additive rather than synergistic fashion. However, their effects could be dissociated in mutants of YAC‐1 cells selected for resistance to the inhibition of IL‐1‐mediated IFN‐γ induction by RAP. Moreover, the IFN‐γ modulatory action of RAP in YAC‐1 cells was accompanied by an antiproliferative effect, whereas TGF‐β1 failed to alter the growth of these cells. Therefore, the immunomodulatory action of TGF‐β1 may result from the dis ruption of biochemical processes related to, although distinct from, those affected by RAP. © 1994 Wiley‐Liss, Inc.</description><identifier>ISSN: 0021-9541</identifier><identifier>EISSN: 1097-4652</identifier><identifier>DOI: 10.1002/jcp.1041600117</identifier><identifier>CODEN: JCLLAX</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Cell physiology ; Fundamental and applied biological sciences. Psychology ; Molecular and cellular biology ; Responses to growth factors, tumor promotors, other factors</subject><ispartof>Journal of cellular physiology, 1994-07, Vol.160 (1), p.141-153</ispartof><rights>Copyright © 1994 Wiley‐Liss, Inc.</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2697-16562673642acc8ad20b24803a60fe09a8453602f1599e85e754bb3348ba11293</citedby><cites>FETCH-LOGICAL-c2697-16562673642acc8ad20b24803a60fe09a8453602f1599e85e754bb3348ba11293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjcp.1041600117$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjcp.1041600117$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4183348$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Dumont, Francis J.</creatorcontrib><creatorcontrib>Kastner, Carolyn A.</creatorcontrib><title>Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a t cell lymphoma: Comparison with the effects of rapamycin</title><title>Journal of cellular physiology</title><addtitle>J. Cell. Physiol</addtitle><description>Transforming growth factor β1 (TGF‐β1) is a multifunctional cytokine whose potent immunomodulatory activity is well documented. To explore the mechanisms of this activity we examined the effect of TGF‐β1 on the production of IFN‐γ measured at the mRNA and protein levels in the YAC‐1 cell lymphoma. In previous studies, this model proved useful to characterize the mode of action of the immunosuppressant rapamycin (RAP). Here, we found that when induced by IL‐1 or IL‐1 + PMA, the production of IFN‐γ is suppressed by both TGF‐β1 (ED50 = 1.9 pM) and RAP (ED50 = 0.2 nM). In contrast, when induced by the calcium ionophore ionomycin, in the absence or in the presence of PMA, this production is enhanced up to 10‐fold by TGF‐β (ED50 = 1.8 pM) and 1.5—3‐fold by RAP. Therefore, in YAC‐1 cells, TGF‐β1 exerts opposite effects on IFN‐γ production depending on the mode of activiation, and these effects parallel those of RAP. To further analyze the mode of action of TGF‐β1 in this system, we used okadaic acid (OA), an inhibitor of serine/threonine protein phosphatases. Treatment with OA rendered the expression of IFN‐γ mRNA induced by IL‐1 insensitive to TGF‐β1 or RAP, indicating that activation of a phosphatase may play a role in the suppressive effect of both agents. However, OA did not prevent the augmentation of ionomycin‐mediated induction of IFN‐β mRNA by either TGF‐β1 or RAP. Hence, the up‐regulation of IFN‐β production by TGF‐β1 and RAP may involve a different biochemical mechanism that that mediating their suppressive action. These observations also favor the hypothesis that the two agents act on the same regulatory pathways. This was further supported by the finding that TGF‐β1 and RAP modulate IFN‐γ production in an additive rather than synergistic fashion. However, their effects could be dissociated in mutants of YAC‐1 cells selected for resistance to the inhibition of IL‐1‐mediated IFN‐γ induction by RAP. Moreover, the IFN‐γ modulatory action of RAP in YAC‐1 cells was accompanied by an antiproliferative effect, whereas TGF‐β1 failed to alter the growth of these cells. Therefore, the immunomodulatory action of TGF‐β1 may result from the dis ruption of biochemical processes related to, although distinct from, those affected by RAP. © 1994 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Cell physiology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Molecular and cellular biology</subject><subject>Responses to growth factors, tumor promotors, other factors</subject><issn>0021-9541</issn><issn>1097-4652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNqFkM1u1DAUhS0EEkNhy9oLtin-T8wORbSlGgFCRSwtx2M3bhM7sj2azmtBn6PPhNuBIlasfOX7nXPvPQC8xugYI0TeXpmlFgwLhDBun4AVRrJtmODkKVhVADeSM_wcvMj5CiEkJaUrcHuRdMguptmHS3iZ4q6M0GlTYoJ3PzD0YfSDL7kWxabJbq99aHDjw2Zr7AYO2wJtGHUwtiIxxHlvKvCn_SByNsXQ3P2ES4r1u1SsNqCGBRo7TXDaz8sYZ_0O9nFedPK5Ajtf9yijhdY5a-r86GDSi37wfwmeOT1l--r3ewS-nXy46M-a9efTj_37dWOIqKdjwQURLRWMaGM6vSFoIKxDVAvkLJK6Y5wKRBzmUtqO25azYaCUdYPGmEh6BI4PvibFnJN1akl-1mmvMFL3mauaufqbeRW8OQgWnY2eXM3W-PyoYri7d6-YPGA7P9n9f0zVef_lnxHNQetzsTePWp2uVT215er7p1PVnfS8X1OpvtJf2Jal3A</recordid><startdate>199407</startdate><enddate>199407</enddate><creator>Dumont, Francis J.</creator><creator>Kastner, Carolyn A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199407</creationdate><title>Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a t cell lymphoma: Comparison with the effects of rapamycin</title><author>Dumont, Francis J. ; Kastner, Carolyn A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2697-16562673642acc8ad20b24803a60fe09a8453602f1599e85e754bb3348ba11293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Biological and medical sciences</topic><topic>Cell physiology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Molecular and cellular biology</topic><topic>Responses to growth factors, tumor promotors, other factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dumont, Francis J.</creatorcontrib><creatorcontrib>Kastner, Carolyn A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Journal of cellular physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dumont, Francis J.</au><au>Kastner, Carolyn A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a t cell lymphoma: Comparison with the effects of rapamycin</atitle><jtitle>Journal of cellular physiology</jtitle><addtitle>J. Cell. Physiol</addtitle><date>1994-07</date><risdate>1994</risdate><volume>160</volume><issue>1</issue><spage>141</spage><epage>153</epage><pages>141-153</pages><issn>0021-9541</issn><eissn>1097-4652</eissn><coden>JCLLAX</coden><abstract>Transforming growth factor β1 (TGF‐β1) is a multifunctional cytokine whose potent immunomodulatory activity is well documented. To explore the mechanisms of this activity we examined the effect of TGF‐β1 on the production of IFN‐γ measured at the mRNA and protein levels in the YAC‐1 cell lymphoma. In previous studies, this model proved useful to characterize the mode of action of the immunosuppressant rapamycin (RAP). Here, we found that when induced by IL‐1 or IL‐1 + PMA, the production of IFN‐γ is suppressed by both TGF‐β1 (ED50 = 1.9 pM) and RAP (ED50 = 0.2 nM). In contrast, when induced by the calcium ionophore ionomycin, in the absence or in the presence of PMA, this production is enhanced up to 10‐fold by TGF‐β (ED50 = 1.8 pM) and 1.5—3‐fold by RAP. Therefore, in YAC‐1 cells, TGF‐β1 exerts opposite effects on IFN‐γ production depending on the mode of activiation, and these effects parallel those of RAP. To further analyze the mode of action of TGF‐β1 in this system, we used okadaic acid (OA), an inhibitor of serine/threonine protein phosphatases. Treatment with OA rendered the expression of IFN‐γ mRNA induced by IL‐1 insensitive to TGF‐β1 or RAP, indicating that activation of a phosphatase may play a role in the suppressive effect of both agents. However, OA did not prevent the augmentation of ionomycin‐mediated induction of IFN‐β mRNA by either TGF‐β1 or RAP. Hence, the up‐regulation of IFN‐β production by TGF‐β1 and RAP may involve a different biochemical mechanism that that mediating their suppressive action. These observations also favor the hypothesis that the two agents act on the same regulatory pathways. This was further supported by the finding that TGF‐β1 and RAP modulate IFN‐γ production in an additive rather than synergistic fashion. However, their effects could be dissociated in mutants of YAC‐1 cells selected for resistance to the inhibition of IL‐1‐mediated IFN‐γ induction by RAP. Moreover, the IFN‐γ modulatory action of RAP in YAC‐1 cells was accompanied by an antiproliferative effect, whereas TGF‐β1 failed to alter the growth of these cells. Therefore, the immunomodulatory action of TGF‐β1 may result from the dis ruption of biochemical processes related to, although distinct from, those affected by RAP. © 1994 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/jcp.1041600117</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9541
ispartof Journal of cellular physiology, 1994-07, Vol.160 (1), p.141-153
issn 0021-9541
1097-4652
language eng
recordid cdi_crossref_primary_10_1002_jcp_1041600117
source Wiley Online Library Journals Frontfile Complete
subjects Biological and medical sciences
Cell physiology
Fundamental and applied biological sciences. Psychology
Molecular and cellular biology
Responses to growth factors, tumor promotors, other factors
title Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a t cell lymphoma: Comparison with the effects of rapamycin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T14%3A55%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transforming%20growth%20factor%20%CE%B21%20inhibits%20interleukin-1-induced%20but%20enhances%20ionomycin-induced%20interferon-%CE%B3%20production%20in%20a%20t%20cell%20lymphoma:%20Comparison%20with%20the%20effects%20of%20rapamycin&rft.jtitle=Journal%20of%20cellular%20physiology&rft.au=Dumont,%20Francis%20J.&rft.date=1994-07&rft.volume=160&rft.issue=1&rft.spage=141&rft.epage=153&rft.pages=141-153&rft.issn=0021-9541&rft.eissn=1097-4652&rft.coden=JCLLAX&rft_id=info:doi/10.1002/jcp.1041600117&rft_dat=%3Cwiley_cross%3EJCP1041600117%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true